Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105541 · ClinicalTrials.gov registry record · NA
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT06105541 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 25 participants.
The verdict
NCT06105541, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Investigate whether at-home transcutaneous auricular VNS (tAN: transcutaneous auricular neurostimulation) improves a battery of nine key physical and psychological symptoms of a group of hEDS (Hypermobile Ehlers-Danlos Syndrome \& Hypermobile Spectrum Disorder) patients (n=30) using a randomized, double blind, sham controlled design. The study team will collect clinical measures at baseline, after a two-week double-blind intervention phase, after a following two-week open-label phase and finally at three months post intervention. The study team will test patients in the following domains: pain, fatigue, sleep, anxiety, depression, quality of life, GI function, immune function and autonomic function.
Interventions
- DEVICE Transcutaneous Auricular Neurostimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2026-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06105541
The ClinicalTrials.gov registry entry for NCT06105541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Auricular Neurostimulation is the first listed.
NCT06105541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06105541 about?
NCT06105541 is a clinical study titled "Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation". Investigate whether at-home transcutaneous auricular VNS (tAN: transcutaneous auricular neurostimulation) improves a battery of nine key physical and psychological symptoms of a group of hEDS (Hypermobile Ehlers-Danlos Syndrome \& Hypermobile Spectrum Disorder) patients (n=30) using a randomized, do...
What is the current status of trial NCT06105541?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-07-05. Estimated completion is 2026-02-04.
What interventions are being tested in trial NCT06105541?
The interventions under investigation include: Transcutaneous Auricular Neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT06105541?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.